Complications associated with injectable soft-tissue fillers: A 5-year retrospective review

JAMA Facial Plastic Surgery

Volumn 15, Issue 3, 2013, Pages 226-231

  Daines, Steven M ^a   Williams, Edwin F ^b  

^a Daines Plastic Surgery   (United States)

^b Williams Center Plastic Surgery Specialists in Latham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; HYALURONIC ACID; HYDROXYAPATITE; LACTIC ACID; POLYLACTIC ACID; POLYMER;

ADULT; AGED; ARTICLE; ESTHETIC SURGERY; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; INJECTION; MIDDLE AGED; OUTCOME ASSESSMENT; REJUVENATION; RETROSPECTIVE STUDY; SKIN DISEASE;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; DURAPATITE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS; LACTIC ACID; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMERS; REJUVENATION; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 84880992707     PISSN: 21686076     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamafacial.2013.798     Document Type: Article

References (23)

1. American Society of Plastic Surgeons. 2011 Plastic surgery procedural statistics. http://www.plasticsurgery.org/News-And-Resources/2011-Statistics-. html.Accessed August 30, 2012.
2. Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg. 2009;35(suppl 2):1672-1680.
3. Emer J, Waldorf H. Injectable neurotoxins and fillers: there is no free lunch. Clin Dermatol. 2011;29(6):678-690.
4. Cox SE. Clinical experience with filler complications. Dermatol Surg. 2009;35(suppl 2):1661-1666.
5. Dayan SH, Arkins JP, Mathison CC. Management of impending necrosis associated with soft tissue filler injections. J Drugs Dermatol. 2011;10(9):1007-1012.
6. Hirsch RJ, Cohen JL, Carruthers JD. Successfulmanagement of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg. 2007;33(3):357-360.
7. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006; 32(2):276-281.
8. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers: focal necrosis and angry red bumps. Dermatol Surg. 2006;32(3):426-434.
9. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg. 2004;114(1):277.
10. Mertz PM. Cutaneous biofilms: friend or foe? Wounds. 2003;15(5):129-132.
11. Monheit GD, Rohrich RJ. The nature of long-term fillers and the risk of complications. Dermatol Surg. 2009;35(suppl 2):1598-1604.
12. Jayaraman A, Wood TK. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng. 2008;10:145-167.
13. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33(suppl 2):S168-S175.
14. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011; 64(1):1-36.
15. Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study. J Am Acad Dermatol. 2008;59(6):923-933.
16. Borelli C, Kunte C, Weisenseel P, Thoma-Greber E, Korting HC, Konz B. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol. 2005;18(6):273-278.
17. Lemperle G, Morhenn VB, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27(5):354-367.
18. Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006;118 (3)(suppl):55S-63S.
19. Butterwick K, Lowe NJ. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol. 2009;61(2):281-293.
20. Sanofi-Aventis U.S. LLC. Sculptra (injectable poly-L-lactic acid) prescribing information. 2009. http://products.sanofi.us/sculptra/sculptra.html. Accessed August 30, 2012.
21. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29(1):34-48.
22. Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg. 2003;29(8):859-862.
23. Ghislanzoni M, Bianchi F, Barbareschi M, Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol. 2006;154(4):755-758.